This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Remedy Informatics First And Only Vendor Authorized To Submit Full Suite Of AGNIS-Supported CIBMTR Forms, Launches "Live In Five" Software Deployment Program

"The value of integrating the BMT service line with cell therapy researchers, labs and biobanks is essential to an enterprise seeking to maximize treatment effectiveness and research investment," said Hank Wu, director of translational informatics at Remedy Informatics. "The combination of ComprehensiveBMT and InvestigateCT facilitates multidirectional flow of data, beginning at the patient's initial admission and evaluation and continuing throughout and after the transplantation procedure, allowing researchers to analyze the entire longitudinal view for new findings that can improve outcomes for current and future patients. This is a tangible way to realize the promise of personalized medicine."

"The traditional data process largely fails to use data from one patient to benefit the next, or to utilize clinical data to inform laboratory research and vice versa," said Dewey. "One of our goals is to introduce a new, fully integrated data paradigm for BMT centers and cell therapy labs around the world."

Remedy Informatics will demo both ComprehensiveBMT and InvestigateCT at the 2013 BMT Tandem Meeting held in the Salt Palace in Salt Lake City, Booth #101. Attendees can also participate in Remedy's "Try Then Buy" campaign in order to "test drive" ComprehensiveBMT prior to purchasing the software.

Remedy's cutting-edge BMT research and reporting software serves clients around the world, including the Huntsman Cancer Institute at the University of Utah, Princess Margaret Hospital, The Jewish – Mercy Health BMT Center, and Primary Children's Medical Center in Salt Lake City, UT. Remedy Informatics products were also recently chosen as the technology solution for the European Group for Blood and Marrow Transplantation (EBMT) Registry Upgrade Project.

To request a demo or to learn more about ComprehensiveBMT and how it can benefit your BMT or cancer treatment center, please visit the product page on our website,

About Remedy Informatics, Inc.Remedy Informatics, Inc. is the leading provider of clinical registries, medical research software and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaicâ„¢ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of life science research and healthcare delivery in the United States and across the globe. For more information visit:

Media Contacts Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell),

SOURCE Remedy Informatics, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.75 -1.10%
FB $117.53 0.69%
GOOG $693.00 0.29%
TSLA $240.75 -2.80%
YHOO $36.61 0.06%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs